P858: FUNCTIONAL STUDIES IN MULTIPLE MYELOMA CELL LINESWITH OVEREXPRESSION OF NRAS Q61R MUTATION

P858: FUNCTIONAL STUDIES IN MULTIPLE MYELOMA CELL LINESWITH OVEREXPRESSION OF NRAS Q61R MUTATION

Bibliographic Details
Main Authors:	Romano Liotti, Angelica Macauda, Rainer Will, Stefano Landi, Federica Gemignani, Federico Canzian
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000970336.69607.62

Similar Items

Transcriptome of melanoma cells from two mouse models, Tyr:NRasQ61Kand Tyr:Rack1-HA, Tyr:NRasQ61K
by: Cécil Campagne, et al.
Published: (2017-10-01)

Giant congenital melanocytic naevus caused by NRAS Q61K mosaicism
by: Carl M. Thielmann, et al.
Published: (2022-12-01)

Crystal structure of NRAS Q61K with a ligand-induced pocket near switch II
by: Teklab Gebregiworgis, et al.
Published: (2024-06-01)

Changes in cell morphology and function induced by the NRAS Q61R mutation in lymphatic endothelial cells.
by: Shiho Yasue, et al.
Published: (2024-01-01)

Changes in cell morphology and function induced by the NRAS Q61R mutation in lymphatic endothelial cells
by: Shiho Yasue, et al.
Published: (2024-01-01)

BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS Q61 -mutated melanomas to targeted therapy
by: Kimberley McGrail, et al.
Published: (2022-11-01)

Rapid progression to AML in a patient with germline GATA2 mutation and acquired NRAS Q61K mutation
by: Lisa J. McReynolds, et al.
Published: (2019-01-01)

PB1969: FUNCTIONAL CHARACTERIZATION OF SUSCEPTIBILITY LOCI TO MULTIPLE MYELOMA
by: M. Shokouhi, et al.
Published: (2022-06-01)

Evaluation of a microarray for genotyping polymorphisms related to xenobiotic metabolism and DNA repair
by: Stefano Landi, et al.
Published: (2003-10-01)

KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
by: Sergiu Pasca, et al.
Published: (2019-10-01)

Liquid Biopsy with Detection of NRAS<sup>Q61K</sup> Mutation in Cerebrospinal Fluid: An Alternative Tool for the Diagnosis of Primary Pediatric Leptomeningeal Melanoma
by: Angela Mastronuzzi, et al.
Published: (2022-07-01)

PB1958: IN SILICO ANALYSIS OF SYNONYMOUS AND NON-SYNONYMOUS SNPS OF THE HUMAN CEREBLON (CRBN) GENE: AN IMPORTANT GENE IN IMMUNOMODULATORY DRUGS (IMIDS)-BASED TREATMENT OF MULTIPLE MYELOMA PATIENTS
by: M. Güler, et al.
Published: (2022-06-01)

Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis
by: Sophie Klemm, et al.
Published: (2023-11-01)

Deciphering Conformational Changes of the GDP-Bound NRAS Induced by Mutations G13D, Q61R, and C118S through Gaussian Accelerated Molecular Dynamic Simulations
by: Zhiping Yu, et al.
Published: (2022-08-01)

Case report: Complete response of an anaplastic thyroid carcinoma patient with NRAS Q61R/BRAF D594N mutations to the triplet of dabrafenib, trametinib and PD-1 antibody
by: Lin Gui, et al.
Published: (2023-04-01)

P858: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR T-CELL CYTOTOXICITY
by: L. Martinez-Verbo, et al.
Published: (2022-06-01)

Next generation sequencing for personalized therapy: About a class III BRAF N581K mutation associated to NRAS Q61L mutation in malignant melanoma: Case report
by: Manuel Croix, et al.
Published: (2023-08-01)

Clinicopathological Significance of BRAF (V600E), NRAS (Q61K) and TERT (C228T, C250T and SNP Rs2853669) Mutations in Bulgarian Papillary Thyroid Carcinoma Patients
by: Vidinov K., et al.
Published: (2021-04-01)

Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome
by: Matteo Giaccherini, et al.
Published: (2024-11-01)

Action of Light on Metabolism of Yeast FT-858
by: Maria do Socorro Mascarenhas Santos, et al.
Published: (2019-09-01)

Malignant Melanoma with Concurrent BRAF E586K and NRAS Q81K Mutations
by: Rodney Shackelford, et al.
Published: (2014-05-01)

The Sec61 translocon is a therapeutic vulnerability in multiple myeloma
by: Antoine Domenger, et al.
Published: (2022-01-01)

Mixed phenotype acute leukemia in a child associated with a NUP98‐NSD1 fusion and NRAS p.Gly61Arg mutation
by: Shireen S. Ganapathi, et al.
Published: (2021-08-01)

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
by: Fidler, C, et al.
Published: (2004)

Corte Suprema. Rol n° 9.858-2013.
by: Roberto Cerón Reyes
Published: (2015-09-01)

NRAS destines tumor cells to the lungs
by: Giannou, AD, et al.
Published: (2017)

NRAS destines tumor cells to the lungs
by: Anastasios D Giannou, et al.
Published: (2017-03-01)

NRAS mutation in differentiated thyroid cancer
by: Saswata Saha, et al.
Published: (2022-01-01)

Ectopic overexpression of Kir6.1 in the mouse heart impacts on the life expectancy
by: Yasuhiro Watanabe, et al.
Published: (2018-08-01)

Deregulated Nras expression in knock-in animals harboring a gammaretroviral long terminal repeat at the Nras/Csde1 locus.
by: Borja Ballarín-González, et al.
Published: (2013-01-01)

miR-145-5p suppresses cell proliferation by targeting IGF1R and NRAS genes in multiple myeloma cells
by: Kaya Murat, et al.
Published: (2023-06-01)

MEK inhibitors for the treatment of NRAS mutant melanoma
by: Sarkisian S, et al.
Published: (2018-08-01)

Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas
by: Daisuke Akahori, et al.
Published: (2021-07-01)

Effect of Cryogenic Treatment on the Properties of Low Carbon A858 Steel
by: Abbas A. Hussein, et al.
Published: (2023-07-01)

Impact of NRAS Mutations on the Diagnosis of Follicular Neoplasm of the Thyroid
by: Ja-Seong Bae, et al.
Published: (2014-01-01)

Advances in the treatment of advanced melanoma with NRAS gene mutation
by: ZHAO Bolun, ZHU Guannan
Published: (2023-10-01)

Acquisition of loss of the wild-type NRAS locus with aggressive disease progression in a patient with juvenile myelomonocytic leukemia and a heterozygous NRAS mutation
by: Kazuyuki Matsuda, et al.
Published: (2007-11-01)

Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma
by: Antoine Domenger, et al.
Published: (2023-01-01)

Historical Study of Yemen’s Celebrations in Time of Tahirids (858-945 A.H)
by: ali gholami firoozjaee, et al.
Published: (2020-08-01)

الملک الاشوری شلمنصر الثالث (858-824 ق.م) - (رسالة ماجستیر)
by: حسین النجم, et al.
Published: (2003-06-01)